• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Otol . SARS-CoV-2 and hearing: an audiometric analysis of COVID-19 hospitalized patients

tetano

Editor, Senior Moderator
J Otol


. 2021 Feb 3.
doi: 10.1016/j.joto.2021.01.005. Online ahead of print.
SARS-CoV-2 and hearing: an audiometric analysis of COVID-19 hospitalized patients


Francisco Alves de Sousa[SUP] 1 [/SUP], Rodrigo Pinto Costa[SUP] 2 [/SUP], Sandra Xar?[SUP] 1 [/SUP], Ana N?brega Pinto[SUP] 1 [/SUP], Cec?lia Almeida E Sousa[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

Purpose: COVID-19 associated hearing loss is still an ongoing matter of debate. No original studies exist on audiological effects of SARS-CoV-2 infection in hospitalized patients. The main objective was to determine whether SARS-CoV-2 may affect auditory function in clinically ill COVID-19 patients.
Materials and methods: COVID-19 patients with moderate-severe disease and without prior history of hearing abnormalities were enrolled from a tertiary referral center, and matched with controls. Participants performed an audiometric evaluation, and thresholds were compared.
Results: 120 ears from 60 patients were enrolled. Patients with COVID-19 showed worse mean auditory thresholds starting from 1000 Hz through higher frequencies, when compared to controls (1000 Hz: 18.52 ? 5.49 dB HL in controls vs 25.36 ? 6.79 dB HL in COVID-19, p<0.001; 2000Hz: 17.50 ? 5.57 dB HL in controls vs 21.96 ? 7.05 dB HL in COVID-19, p=0.010; 3000Hz: 17.97 ? 8.07 dB HL in controls vs 25 ? 9.38 dB HL in COVID-19, p=0.003; 4000 Hz: 20.16 ? 10.12 dB HL in controls vs 29.55 ? 11.26 dB HL in COVID-19, p=0.001; 8000 Hz: 31.09 ? 12.75 dB HL in controls vs 40.71 ? 19.40 dB HL in COVID-19, p=0.030; Pure Tone Average: 20.42 ? 4.29 dB HL in controls vs 24.85 ? 5.62 dB HL in COVID-19, p=0.001). Statistical significance persisted after adjusting for confounders such as age, gender and various comorbidities (p<0.05).
Conclusions: SARS-CoV-2 may affect hearing in COVID-19 patients with moderate-severe disease. Results are in line with the previous suggested effects of COVID-19 on auditory system. This study is expected to encourage further research on this topic.

Keywords: Audiometry; COVID-19; Coronavirus; Hearing; SARS-CoV-2.
 
Back
Top Bottom